A Sydney Rock Oyster Hymolymph are Shows Antimicrobial Properties to Mitigate Bacterial Infections
Abstract
The Sydney rock oyster (Saccostrea glomerata) is a native bivalve mollusk found in estuarine and coastal waters of Australia and holds significant ecological and commercial importance. As a filter-feeder, it is constantly exposed to microbial pathogens and relies on its innate immune system for protection. A major component of this defense is the haemolymph, which contains antimicrobial proteins and peptides. Recent studies have shown that haemolymph exhibits antibacterial activity against a range of Gram-positive and Gram-negative bacteria, inhibits biofilm formation, and can enhance the effectiveness of conventional antibiotics. These properties highlight its potential as a natural source of novel antimicrobial agents. However, Sydney rock oysters are susceptible to diseases such as juvenile oyster disease (JOD), QX disease caused by Marteilia sydneyi, and herpesvirus infections, which threaten aquaculture productivity. Understanding haemolymph’s antimicrobial properties offers potential strategies to mitigate bacterial infections and improve oyster health management.
References
Google Search. (n.d.). Antibacteria: Definition and types.
Murray, C. J., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., et al. (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. The Lancet, 399(10325).
Romandini, A., Pani, A., Schenardi, P. A., Pattarino, G. A. C., De Giacomo, C., & Scaglione, F. (2021). Antibiotic resistance in pediatric infections: Global emerging threats, predicting the near future. Antibiotics, 10(4).
Hall-Stoodley, L., & Stoodley, P. (2009). Evolving concepts in biofilm infections. Cellular Microbiology.
American Society for Microbiology. (2023). Antibiotic adjuvants for combatting antimicrobial resistance. https://asm.org/Articles/2023/January/Antibiotic-Adjuvants-for-Combatting-Antimicrobial
Magana, M., Pushpanathan, M., Santos, A. L., Leanse, L., Fernandez, M., Ioannidis, A., et al. (2020). The value of antimicrobial peptides in the age of resistance. The Lancet Infectious Diseases, 20(9), e216–e230.
Moretta, A., Scieuzo, C., Petrone, A. M., Salvia, R., Manniello, M. D., Franco, A., et al. (2021). Antimicrobial peptides: A new hope in biomedical and pharmaceutical fields. Frontiers in Cellular and Infection Microbiology, 11.
Lazzaro, B. P., Zasloff, M., & Rolff, J. (2020). Antimicrobial peptides: Application informed by evolution. Science, 368(6490).
Chaparro, E., & da Silva, P. I., Jr. (2016). Lacrain: The first antimicrobial peptide from the body extract of the Brazilian centipede Scolopendra viridicornis. International Journal of Antimicrobial Agents, 48(3), 277–285.
Lázár, V., Martins, A., Spohn, R., Daruka, L., Grézal, G., Fekete, G., et
al. (2018). Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides. Nature Microbiology, 3(6), 718–731. https://doi.org/10.1038/s41564-018-0164-0
Refbacks
- There are currently no refbacks.